Faller Douglas Vincent

Reported to SECin USFilings at 1 company

No score on this page, by design. These filings come from the American register (SEC). We show them as facts, with what the share price did since each filing and since each trade; our scores, percentiles and signals run on the Dutch register only, because that is the only register the model has been validated on.

This page is free to read, and it stops after 5 rows. Those are the 5 most recent filings by this filer, out of 7. Reading the whole list, and the full version of the page each row opens (that page itself opens free, with its first rows), is part of the subscription. So are this filer’s key figures and the price change beside each line, since the filing and since the trade. What that costs is on the pricing page. Already subscribed? Sign in and this page opens in full.

The most recent filings

Most recent filing first. Reported is the day the filing reached the regulator, usually a few days after the trade itself.

5 of 7
Reported insider transactions
CompanyTypeValueReportedCompanyValueTypeSharesReported
Imunon, Inc.Chief Medical OfficerAward$6,1904,390 sharesSep 28, 2026Imunon, Inc.Chief Medical Officer$6,190Award · Sep 28Award4,390Sep 28, 2026
Imunon, Inc.Chief Medical OfficerAward$6,1904,211 sharesSep 15, 2026Imunon, Inc.Chief Medical Officer$6,190Award · Sep 15Award4,211Sep 15, 2026
Imunon, Inc.Chief Medical OfficerAward$5,8023,626 sharesSep 1, 2026Imunon, Inc.Chief Medical Officer$5,802Award · Sep 1Award3,626Sep 1, 2026
Imunon, Inc.Chief Medical OfficerAward$5,8013,516 sharesAug 17, 2026Imunon, Inc.Chief Medical Officer$5,801Award · Aug 17Award3,516Aug 17, 2026
Imunon, Inc.Chief Medical OfficerAward$5,8023,649 sharesAug 4, 2026Imunon, Inc.Chief Medical Officer$5,802Award · Aug 4Award3,649Aug 4, 2026